SI-Bone, Inc.
SEC CIK 1459839 · SIBN · last insider filing 2026-06-09
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Hilleman Jeryl L | Director | filed 2019 - 2026 |
| Dunn Jeffrey W | Director · Chairman, President & CEO | filed 2018 - 2026 |
| Freund John Gordon | Director | filed 2018 - 2026 |
| Davis Timothy E JR | Director | filed 2018 - 2026 |
| West Thomas A. | Director | filed 2024 - 2026 |
| Nishimura Mika | Director | filed 2021 - 2026 |
| Francis Laura | Director · Chief Financial Officer | filed 2018 - 2026 |
| Hinckley Greg K | Director | filed 2018 - 2026 |
| Wolf Daniel W | Director | filed 2024 - 2025 |
| Valentine Keith | Director | filed 2018 - 2023 |
| Loh Helen | Director | filed 2021 - 2023 |
| Licitra Karen A | Director | filed 2018 - 2021 |
| Foley Mark J | Director | filed 2019 - 2020 |
| Donigan Heyward R | Director | filed 2019 - 2019 |
| Reiley Mark A | Director | filed 2018 - 2019 |
| Orbimed Advisors LLC | Director | filed 2018 - 2018 |
| Bonita David P | Director | filed 2018 - 2018 |
| Petersen Timothy | Director | filed 2018 - 2018 |
| Orbimed Capital GP V LLC | Director | filed 2018 - 2018 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Pisetsky Michael A | SVP, Ops & Adm/Chief Legal Ofr | filed 2018 - 2026 |
| Maheshwari Anshul | Chief Financial Officer | filed 2021 - 2026 |
| Recupero Anthony J | President, Commercial Ops | filed 2018 - 2026 |
| Yerby Scott A | Chief Technology Officer | filed 2018 - 2020 |
| Reckling W Carlton | CMO and VP, Medical Affairs | filed 2018 - 2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.